TRex Bio Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • TRex Bio's estimated annual revenue is currently $9.8M per year.(i)
  • TRex Bio's estimated revenue per employee is $155,000

Employee Data

  • TRex Bio has 63 Employees.(i)
  • TRex Bio grew their employee count by -17% last year.

TRex Bio's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Chief Operating OfficerReveal Email/Phone
3
Chief Scientific OfficerReveal Email/Phone
4
Head ResearchReveal Email/Phone
5
VP Biology and PharmacologyReveal Email/Phone
6
Head DiscoveryReveal Email/Phone
7
DirectorReveal Email/Phone
8
Director, Computational BiologyReveal Email/Phone
9
Executive Director, Head Computational BiologyReveal Email/Phone
10
DirectorReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.4M70-8%$53MN/A
#2
$32.4M167-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.8M1813%N/AN/A
#5
$0.8M5-50%N/AN/A
#6
$0.8M100%N/AN/A
#7
$14M90-12%N/AN/A
#8
$0.4M33610%$236.7MN/A
#9
$4.8M62-74%$160MN/A
#10
$3.7M24-8%N/AN/A
Add Company

What Is TRex Bio?

TRex Bio is a stealth mode, discovery-stage biotechnology company focused on making a meaningful difference in the lives of patients suffering from fatal or debilitating illnesses including cancer, fibrotic, autoimmune and inflammatory diseases. Our translationally driven discovery engine has generated a deep understanding of human immunobiology in healthy and diseased tissues. Through a comprehensive interrogation of human tissue-resident immune cells, we have begun to elucidate the molecular pathways utilized by these cells, with a focus on regulatory T cells (Tregs). Functional manipulation of Tregs in a tissue-specific and disease-specific fashion will result in transformative therapies to treat multiple diseases. We have raised a substantial Series A to date. Our people are collaborative, data-driven and curious. Join the team before our big reveal!

keywords:N/A

N/A

Total Funding

63

Number of Employees

$9.8M

Revenue (est)

-17%

Employee Growth %

N/A

Valuation

N/A

Accelerator

TRex Bio News

2022-04-20 - USDA fertilizer grant program eyed to fund expansion of ...

... (sim-trex), a biobased granular fertilizer line with analyses of ... adds the nutrients to make what she calls “a bio-based fertilizer...

2022-04-13 - Bio-Composites Consumption Market Growth 2022-2030| Key ...

Bio-Composites Consumption Market Growth 2022-2030| Key Players – Trex, UPM, Universal Forest Products, Flexform Technologies.

2022-03-22 - TRexBio Completes $26 Million Series A Extension Led by ...

TRexBio is a discovery stage biotechnology company leveraging cutting edge computational biology tools, a focus on human tissue, and expertise...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7.7M63-30%N/A
#2
$8.2M637%N/A
#3
$15M630%N/A
#4
$7.1M63-19%$10M
#5
$11.9M6324%N/A